143 related articles for article (PubMed ID: 34397335)
1. Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways.
Maher A; El Sayed N; Nafea H; Gad M
CNS Neurol Disord Drug Targets; 2022; 21(7):631-639. PubMed ID: 34397335
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
[TBL] [Abstract][Full Text] [Related]
3. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects.
Guo H; Cheng Y; Wang C; Wu J; Zou Z; Niu B; Yu H; Wang H; Xu J
Neuropharmacology; 2017 Apr; 116():260-269. PubMed ID: 28065587
[TBL] [Abstract][Full Text] [Related]
4. Caffeine-induced protein kinase A activation restores cognitive deficits induced by sleep deprivation by regulating
Tran TT; Park J; Kim DY; Han IO
Am J Physiol Cell Physiol; 2024 Mar; 326(3):C978-C989. PubMed ID: 38314722
[TBL] [Abstract][Full Text] [Related]
5. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injury.
Titus DJ; Sakurai A; Kang Y; Furones C; Jergova S; Santos R; Sick TJ; Atkins CM
J Neurosci; 2013 Mar; 33(12):5216-26. PubMed ID: 23516287
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.
Cheng YF; Wang C; Lin HB; Li YF; Huang Y; Xu JP; Zhang HT
Psychopharmacology (Berl); 2010 Oct; 212(2):181-91. PubMed ID: 20640406
[TBL] [Abstract][Full Text] [Related]
8. Sleep deprivation impairs cAMP signalling in the hippocampus.
Vecsey CG; Baillie GS; Jaganath D; Havekes R; Daniels A; Wimmer M; Huang T; Brown KM; Li XY; Descalzi G; Kim SS; Chen T; Shang YZ; Zhuo M; Houslay MD; Abel T
Nature; 2009 Oct; 461(7267):1122-5. PubMed ID: 19847264
[TBL] [Abstract][Full Text] [Related]
9. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement.
Hosseini-Sharifabad A; Ghahremani MH; Sabzevari O; Naghdi N; Abdollahi M; Beyer C; Bollen E; Prickaerts J; Roghani A; Sharifzadeh M
Pharmacol Biochem Behav; 2012 May; 101(3):311-9. PubMed ID: 22306745
[TBL] [Abstract][Full Text] [Related]
10. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
Nagakura A; Niimura M; Takeo S
Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors.
Arcaro CA; Assis RP; Oliveira JO; Zanon NM; Paula-Gomes S; Navegantes LCC; Kettelhut IC; Brunetti IL; Baviera AM
Life Sci; 2021 Aug; 278():119563. PubMed ID: 33930364
[TBL] [Abstract][Full Text] [Related]
12. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E
Hum Mol Genet; 2011 Nov; 20(21):4232-47. PubMed ID: 21835884
[TBL] [Abstract][Full Text] [Related]
13. Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels.
Zhong Y; Zhu Y; He T; Li W; Yan H; Miao Y
Neurosci Lett; 2016 Jan; 610():171-6. PubMed ID: 26552011
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
[TBL] [Abstract][Full Text] [Related]
15. Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling.
Cong YF; Liu FW; Xu L; Song SS; Shen XR; Liu D; Hou XQ; Zhang HT
Int J Neuropsychopharmacol; 2023 Sep; 26(9):585-598. PubMed ID: 37490542
[TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats.
Wang C; Yang XM; Zhuo YY; Zhou H; Lin HB; Cheng YF; Xu JP; Zhang HT
Int J Neuropsychopharmacol; 2012 Jul; 15(6):749-66. PubMed ID: 21733236
[TBL] [Abstract][Full Text] [Related]
17. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
Tiwari S; Felekkis K; Moon EY; Flies A; Sherr DH; Lerner A
Blood; 2004 Apr; 103(7):2661-7. PubMed ID: 14615375
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
19. cAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress.
Luo Y; Kuang S; Li H; Ran D; Yang J
Oncotarget; 2017 May; 8(22):35558-35572. PubMed ID: 28415673
[TBL] [Abstract][Full Text] [Related]
20. Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.
Boomkamp SD; McGrath MA; Houslay MD; Barnett SC
Br J Pharmacol; 2014 May; 171(9):2385-98. PubMed ID: 24467222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
